Avalo Therapeutics grants inducement stock options for 101,600 shares at $15.47

Avalo Therapeutics granted inducement stock options covering 101,600 shares to three newly hired employees. Options were issued Sept. 25, 2026 at an exercise price of $15.47 per share, with 25% vesting after one year from each start date and the remainder vesting monthly over 36 months.